Physician profile

David A Cooley

Neurological Surgery · Lima, OH

NPI 1528134582

$1,734.00

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$107.07
Travel and Lodging$65.75

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Nevro Corp. $1,273.37 2022-2023 Senza
Medtronic USA, INC. $249.12 2019-2020
Depuy Synthes Sales INC. $119.16 2019-2020
Stryker Corporation $27.93 2019
Kls-Martin L.P. $19.12 2020
Glaxosmithkline, LLC. $12.28 2019
Janssen Biotech, INC. $12.03 2021
Globus Medical, INC. $11.49 2019
Orthofix Medical, INC. $9.50 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David A Cooley

$1,734.00

in general payments reported 2019-2025

Years
2019-2023
Top company
Nevro Corp.

https://glasscript.com/doctor/341084/david-a-cooley

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.